Covalon Technologies Ltd. (TSXV:COV)
Canada · Delayed Price · Currency is CAD 2.330
0.00 (0.00%)
Aug 21, 2026, 12:00 PM EST
Covalon Technologies Market Cap
Covalon Technologies has a market cap or net worth of CAD 64.35 million as of August 21, 2026. Its market cap has decreased by -18.51% in one year.
Market Cap
64.35M
Enterprise Value
49.56M
Revenue
32.68M
Ranking
n/a
PE Ratio
46.76
Stock Price
2.33
ChartMarket Cap Chart
Since September 3, 2004, Covalon Technologies's market cap has increased from 3.06M to 64.35M, an increase of 2,001.09%. That is a compound annual growth rate of 14.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 64.35M | 34.88% |
| Dec 31, 2025 | 47.71M | -46.42% |
| Dec 31, 2024 | 89.04M | 240.51% |
| Dec 29, 2023 | 26.15M | -55.61% |
| Dec 30, 2022 | 58.91M | -14.07% |
| Dec 31, 2021 | 68.55M | 130.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.83B |
| Extendicare | 2.90B |
| Sienna Senior Living | 2.39B |
| Green Thumb Industries | 2.24B |
| NurExone Biologic | 65.14M |
| NetraMark Holdings | 63.40M |
| Cannabix Technologies | 62.65M |
| Victory Square Technologies | 62.53M |